0
1094
Bill Ackman’s Struggles In One Chart
At this point the schadenfreude amongst investors for Bill Ackman and his hedge fund Pershing Square, has to be reaching a peak. Over the past 48 hours Valeant Pharmaceuticals’ stock has declined 19% largely as a result of the company revealing that it was being investigated by the Securities and Exchange Commission. The below chart...